We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Baxter International
BAX
$14.1B
| $260M | 0.51% |
5,714,413
-265,373
| -4% | -$11.6M |
|
27
Procter & Gamble
PG
$342B
| $258M | 0.5% |
1,697,775
-324,001
| -16% | -$48.8M |
|
28
Citigroup
C
$231B
| $256M | 0.5% |
5,570,637
+1,914,533
| +52% | +$89.7M |
|
29
Hasbro
HAS
$12.9B
| $249M | 0.49% |
3,843,734
+3,290,766
| +595% | +$192M |
|
30
Elevance Health
ELV
$84.8B
| $237M | 0.46% |
533,095
-12,570
| -2% | -$5.8M |
|
31
Crocs
CROX
$6.58B
| $236M | 0.46% |
2,100,807
+590,956
| +39% | +$70.4M |
|
32
Moody's
MCO
$83.8B
| $220M | 0.43% |
632,168
-28,839
| -4% | -$9.14M |
|
33
Pinterest
PINS
$13.1B
| $215M | 0.42% |
7,868,271
-5,790,804
| -42% | -$144M |
|
34
DexCom
DXCM
$31.2B
| $211M | 0.41% |
1,640,594
-1,315,849
| -45% | -$159M |
|
35
Interactive Brokers
IBKR
$39.5B
| $203M | 0.4% |
9,790,156
+2,483,184
| +34% | +$49M |
|
36
Chevron
CVX
$371B
| $202M | 0.4% |
1,285,772
-743,952
| -37% | -$119M |
|
37
Celsius Holdings
CELH
$7.45B
| $199M | 0.39% |
4,004,160
+2,973,612
| +289% | +$118M |
|
38
Dollar General
DG
$28B
| $199M | 0.39% |
+1,172,552
| New | +$232M |
|
39
Mastercard
MA
$500B
| $195M | 0.38% |
497,000
-51,352
| -9% | -$19.3M |
|
40
MongoDB
MDB
$30.3B
| $195M | 0.38% |
473,380
-123,914
| -21% | -$36.1M |
|
41
Cboe Global Markets
CBOE
$29.7B
| $194M | 0.38% |
1,405,139
+71,297
| +5% | +$9.73M |
|
42
Sea Limited
SE
$70.4B
| $194M | 0.38% |
3,338,448
+2,754,034
| +471% | +$196M |
|
43
S&P Global
SPGI
$121B
| $191M | 0.37% |
477,661
-226,441
| -32% | -$82.7M |
|
44
Mercado Libre
MELI
$97.5B
| $191M | 0.37% |
160,983
-102,491
| -39% | -$129M |
|
45
Equifax
EFX
$20.8B
| $188M | 0.37% |
800,759
+548,271
| +217% | +$115M |
|
46
T-Mobile US
TMUS
$186B
| $187M | 0.36% |
1,345,141
+1,309,172
| +3,640% | +$184M |
|
|
47
Adobe
ADBE
$103B
| $186M | 0.36% |
380,200
-674,305
| -64% | -$272M |
|
48
Tenet Healthcare
THC
$21.1B
| $186M | 0.36% |
2,281,465
+1,646,137
| +259% | +$117M |
|
49
UnitedHealth
UNH
$375B
| $178M | 0.35% |
371,016
-91,991
| -20% | -$45M |
|
50
Lockheed Martin
LMT
$133B
| $178M | 0.35% |
387,172
+255,030
| +193% | +$118M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.